𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zidovudine treatment of the AIDS dementia complex: Results of a placebo-controlled trial

✍ Scribed by Dr John J. Sidtis; Constantine Gatsonis; Richard W. Price; Elyse J. Singer; Ann C. Collier; Douglas D. Richman; Martin S. Hirsch; Frederick W. Schaerf; Margaret A. Fischl; Karl Kieburtz; David Simpson; Matthew A. Koch; Judith Feinberg; Urania Dafni


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
718 KB
Volume
33
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Analysis of myopathy in a placebo-contro
✍ David M. Simpson; Peter Slasor; Urania Dafni; Joseph Berger; Margaret A. Fischl; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 2 views

## Methods Myopathy occurs in association with human immunodeficiency virus type 1 (HIV-1) infection, 2,8,17,19 and AIDS Clinical Trials Group (ACTG) Protocol 016 was designed to explore the safety and efficacy of ZDV as toxicity of the antiretroviral agent zidovudine (ZDV, AZT). 3,6,9,15 Retrospe

Interferon-Ξ± and zidovudine combination
✍ Harry L. A. Janssen; Luuk Berk; Rudolf A. Heijtink; Fiebo J. W. Ten Kate; Solko πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 630 KB

Interferon-a therapy leads to HBeAg seroconversion in only one third of patients with chronic hepatitis B. In an attempt to increase the seroconversion rate, we investigated the combination of interferon-a and zidovudine in a subset of patients with presumably low response rates for interferon-a mon

Risperidone for psychosis of Alzheimer's
✍ Henry Brodaty; David Ames; John Snowdon; Michael Woodward; Jeff Kirwan; Roger Cl πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## Objective: To evaluate the efficacy and safety of low-dose risperidone in treating psychosis of alzheimer's disease (ad) and mixed dementia (md) in a subset of nursing-home residents who had dementia and aggression and who were participating in a randomized placebo-controlled trial of risperidon